Aristeromycin/adenosine derivatives
CA 1315779 C · Owner: Prakash, Nellikunja J. · Inventors: Jarvi, Esa T.; Mccarthy, James R.; Prakash, Nellikunja J.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
This invention relates to an aristeromycin/adenosine derivative of the formula, wherein, V is oxy or methylene X1 and X2 are each independently hydrogen or halogen with the proviso that at least one of X1 and X2 is always a halogen atom, A1 and A2 are each independently hydrogen halogen, or hydroxy with the provisos that where A1 is hydroxy, A2 is hydrogen, and that where A2 is hydroxy, A1 is hydrogen, Y1 is nitrogen a CH group, a CCl group, a CBr group, or a CNH2 group Y2 and Y3 are each independently nitrogen or a CH group, Q is NH2, NHOH, NHCH3, or hydrogen and, Z is hydrogen, halogen, or NH2;, or a pharmaceutically acceptable salt thereof which are, useful in inhibiting AdoMet-dependent …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Granted April 6, 1993. A Canadian patent filed before October 1, 1989 lasted 17 years from grant, so its term ended April 6, 2010.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.